Vol 12, No 2 (April 28, 2023): Chinese Clinical Oncology

Editorial Commentary

Pembrolizumab for second line treatment of advanced hepatocellular carcinoma—who would benefit?
Morten Ladekarl
Chinese Clinical Oncology  
2023;
12
(2)
:10
.
 (28 April 2023) 
PDF Full Text (1280) COI Form Open Access Get Permission
Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)
Paula Fernández-Palanca, José L. Mauriz
Chinese Clinical Oncology  
2023;
12
(2)
:11
.
 (28 April 2023) 
PDF Full Text (1570) COI Form Open Access Get Permission
Rezvilutamide: yet another androgen receptor pathway inhibitor for metastatic hormone-sensitive prostate cancer?
Jeanny B. Aragon-Ching
Chinese Clinical Oncology  
2023;
12
(2)
:12
.
 (28 April 2023) 
PDF Full Text (2385) COI Form Open Access Get Permission

Review Article

A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option
Fabio Melandro, Riccardo Aurelio Nasto, Michael Ginesini, Emanuele Balzano, Maria Lucia Bindi, Davide Ghinolfi, Quirino Lai
Chinese Clinical Oncology  
2023;
12
(2)
:13
.
 (28 April 2023) 
PDF Full Text (3267) Reporting Checklist COI Form Open Access Get Permission
Targeted therapies in advanced biliary tract cancers—a narrative review
Michael LaPelusa, Thatcher Heumann, Laura Goff, Rajiv Agarwal
Chinese Clinical Oncology  
2023;
12
(2)
:14
.
 (28 April 2023) 
PDF Full Text (3499) Reporting Checklist COI Form Open Access Get Permission
Management of locally advanced intrahepatic cholangiocarcinoma: a narrative review
Luke Bressler, Natalie Bath, Ashish Manne, Eric Miller, Jordan M. Cloyd
Chinese Clinical Oncology  
2023;
12
(2)
:15
.
 (28 April 2023) 
PDF Full Text (3555) Reporting Checklist Peer Review File COI Form Open Access Get Permission
The robotic future of minimally invasive cytoreduction and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies
Joanna Ortega, Theofano Orfanelli, Edward Levine, Ioannis T. Konstantinidis
Chinese Clinical Oncology  
2023;
12
(2)
:16
.
 (28 April 2023) 
PDF Full Text (2621) Peer Review File COI Form Open Access Get Permission
Image-guided percutaneous locoregional therapies for hepatocellular carcinoma
Olivier Chevallier, Ken Zhao, Brett Marinelli, Hooman Yarmohammadi
Chinese Clinical Oncology  
2023;
12
(2)
:17
.
 (28 April 2023) 
PDF Full Text (3306) Peer Review File COI Form Open Access Get Permission
Single cell sequencing of neutrophils demonstrates phenotypic heterogeneity and functional plasticity in health, disease, and cancer
Alistair S. McLaren, Rana Fetit, Colin S. Wood, John Falconer, Colin W. Steele
Chinese Clinical Oncology  
2023;
12
(2)
:18
.
 (28 April 2023) 
PDF Full Text (7115) Peer Review File COI Form Open Access Get Permission
The emerging role for CAR T cells in solid tumor oncology
Sebastian Klobuch, Tom T. P. Seijkens, John B. A. G. Haanen
Chinese Clinical Oncology  
2023;
12
(2)
:19
.
 (28 April 2023) 
PDF Full Text (3948) Peer Review File COI Form Open Access Get Permission